Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX -41.90%21 3-Year FCF Growth Rate is 91.60% as of Jun. 2026, which is 0% above its 10-year median of 91.45. GuruFocus rates CDIX with a GF Score™ of 21/100 and a GF Value™ of $0.37 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 463 Healthcare Providers & Services companies, Cardiff Lexington ranks better than 95.46% on this metric.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 91.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Cardiff Lexington was 91.60% per year. The lowest was 91.30% per year. And the median was 91.45% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Cardiff Lexington 3-Year FCF Growth Rate Related Terms
CDIX vs NIVF, RHEP, XCRT: 3-Year FCF Growth Rate Comparison
For the Medical Care Facilities subindustry, Cardiff Lexington's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 91.60% mean?
Cardiff Lexington (CDIX) has a 3-Year FCF Growth Rate of 91.60% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Cardiff Lexington and its competitors. This is near median its historical median of 91.45. Over the past decade, Cardiff Lexington's 3-Year FCF Growth Rate has ranged from 91.30 to 91.60. According to the industry distribution chart, Cardiff Lexington ranks #21 out of 463 companies in the Healthcare Providers & Services industry, placing it in the top 4.5%.
Is Cardiff Lexington's 3-Year FCF Growth Rate too high?
Cardiff Lexington's current 3-Year FCF Growth Rate of 91.60% is near median its 10-year median of 91.45. Over the past 10 years, this metric has ranged from a low of 91.30 to a high of 91.60. The Healthcare Providers & Services industry median 3-Year FCF Growth Rate is 12.40. Cardiff Lexington's value of 91.60% is 638.7% above this industry median. Based on the distribution chart, Cardiff Lexington ranks #21 out of 463 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cardiff Lexington has a GF Score™ of 21/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's 3-Year FCF Growth Rate compare to NIVF and RHEP?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #21 out of 463 companies for 3-Year FCF Growth Rate. This places Cardiff Lexington in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 12.40. Cardiff Lexington's value of 91.60% is 638.7% above this benchmark. Historically, Cardiff Lexington's own 3-Year FCF Growth Rate has ranged from 91.30 to 91.60 over the past decade. While the company's 10-year median is 91.45 vs. the industry median of 12.40, Cardiff Lexington has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 12.40, based on 463 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardiff Lexington's current 3-Year FCF Growth Rate of 91.60% is 638.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Cardiff Lexington and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current 3-Year FCF Growth Rate is 91.60%, which is near median its own 10-year median of 91.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Possible Value Trap. The stock's GF Value™ is $0.37, compared to a current price of $0.12 — trading 68.6% below its estimated fair value. The current 3-Year FCF Growth Rate is 91.60%, which is near median its 10-year median of 91.45 and 638.7% above the Healthcare Providers & Services industry median of 12.40. Cardiff Lexington's overall GF Score™ is 21/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current 3-Year FCF Growth Rate is 91.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be undervalued.
The current stock price of $0.12 is trading 68.6% below its estimated GF Value™ of $0.37.
GuruFocus considers Cardiff Lexington to be Possible Value Trap.
Key valuation signals for CDIX:
3-Year FCF Growth Rate: 91.60% (near median its 10-year median of 91.45)
GF Value™: $0.37 vs. price of $0.12 (68.6% below fair value)
Industry Position: 638.7% above the Healthcare Providers & Services median (#21 of 463)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
21GF Score
Get the complete analysis for CDIX
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
